Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
ReoPro
Synonyms :
Class :
Antiplatelet agents; Glycoprotein receptor antagonists
Brand Name :
ReoPro
Synonyms :
Class :
Antiplatelet agents; Glycoprotein receptor antagonists
Dosage forms & Strengths:Â
Adult:Â
IV solution:Â
2 mg/mlÂ
10–60 minutes before to the initiation of PCI, administer a 0.25 mg/kg IV bolus over at least one minute
following, 12 hours of continuous infusion of 0.125 mcg/kg/min through IV; maximum infusion rate is 10 mcg/min
10–60 minutes before to the initiation of PCI, administer a 0.25 mg/kg IV bolus over at least one minute
following, 12 hours of continuous infusion of 0.125 mcg/kg/min through IV; maximum infusion rate is 10 mcg/min
Safety and efficacy are not seen in pediatricsÂ
may diminish the therapeutic effect of vaccines
vaccinia immune globulin intravenous (Rx)
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect of vaccines
measles mumps and rubella vaccine, live
may diminish the therapeutic effect of vaccines
abciximab: it may decrease the excretion rate of abacavir CNS depressant
abciximab: it may decrease the excretion rate of abacavir CNS depressant
abciximab: it may decrease the excretion rate of abacavir CNS depressant
abciximab: it may decrease the excretion rate of abacavir CNS depressant
abciximab: it may decrease the excretion rate of abacavir CNS depressant
measles, mumps, rubella and varicella vaccine, liveÂ
may decrease the therapeutic effects of vaccine
may increase the risk of toxic effects when combined
may increase the risk or severity of adverse effects when combined
may increase the risk or severity of adverse effects when combined
may enhance the risk of hemorrhage when combined with abciximab
it increases the adverse effects caused due to eptinezumab
may enhance the effects of the other by pharmacodynamic synergism
The efficacy of abciximab may be increased by aspirin rectal due to pharmacodynamic synergism
may enhance the thrombogenic effect of immune globulin
may enhance the thrombogenic effect of immune globulin
poliovirus vaccine, live, trivalent
may diminish the therapeutic effect of vaccines
poliovirus vaccine inactivated
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
it may enhance the adverse effects when combined with aducanumab
The combination of antipyrine with abciximab might elevate the severity of hemorrhage & bleeding
The effectiveness of abciximab may be reduced when administered in conjunction with cefotiam
it may enhance the risk of bleeding when combined with mitomycin
ximelagatran (investigational)Â
Combining ximelagatran with abciximab may elevate the risk or seriousness of bleeding
The potential for bleeding risk or its seriousness may elevate when abciximab is used together with troxerutin
When abciximab is used together with piroxicam, this leads to increased risk or seriousness of hemorrhage & bleeding
When andrographolide is used together with abciximab, this leads to enhanced risk or seriousness of bleeding
When abciximab is used together with polythiazide, this leads to a reduction in the therapeutic effectiveness of abciximab
when lonazolac is coupled with abciximab, the risk or severity of bleeding and hemorrhage is enhanced
When abciximab is used together with cyclothiazide, this results in a reduction in abciximab's therapeutic efficacy
combining buflomedil and abciximab may increase the likelihood or intensity of bleeding
the risk of bleeding and hemorrhage may increase when isoxicam is combined with abciximab
the risk of bleeding can be heightened when sulfinpyrazone is combined with abciximab
the risk of bleeding and hemorrhage can be raised when sulindac is combined with abciximab
combining abciximab with taurocholic acid may heighten the risk or intensity of adverse effects
combining abciximab with volociximab may heighten the chances of adverse effects
using clonixin in conjunction with abciximab may increase the likelihood or extent of bleeding and hemorrhaging
the risk or extent of bleeding and hemorrhage can be increased when flunixin is combined with abciximab
the risk or extent of bleeding and hemorrhage can be increased when tepoxalin is combined with abciximab
diethylstilbestrol may lessen the anticoagulant effects of abciximab
the risk or extent of bleeding and hemorrhage can be increased when niflumic acid is combined with abciximab
antithymocyte globulin rabbitÂ
the risk or extent of adverse effects can be raised when abciximab is combined with anti-thymocyte immunoglobulin (rabbit)
chlorotrianisene may lower the anticoagulant activities of abciximab
It may enhance the adverse effects when combined with sotrovimab
It may enhance the risk of bleeding when combined with nimesulide
efficacy of abciximab is altered with cefmetazole
an increase in the bleeding severity can be observed when kebuzone is administered with abciximab
when used with abciximab, andexanet alfa's therapeutic efficacy may be compromised
the anticoagulant activities of abciximab may be increased by carbimazole
the risk of hemorrhage and bleeding can be enhanced
the risk of adverse effects is increased
the risk of hemorrhage may be increased
the risk of hemorrhage or bleeding may be increased
the risk of hemorrhage and bleeding may be increased
the risk of hemorrhage and bleeding may be increased
the risk of hemorrhage and bleeding may be increased
the risk of hemorrhage and bleeding may be increased
the risk of adverse effects may be increased
the risk of bleeding may be increased
the risk of bleeding may be increased
the risk of hemorrhage and bleeding may be increased
the anticoagulant activity of abciximab may be reduced
technetium Tc-99m arcitumomabÂ
the extent of adverse effects can be raised when abciximab is used in combination
choline magnesium trisalicylateÂ
the hazard or intensity of bleeding and hemorrhage can be heightened when Choline magnesium trisalicylate is coupled with abciximab
the therapeutic activity may be reduced
measles, mumps, rubella, and varicella vaccine, live (Rx)
they decrease the efficacy of live vaccines
measles mumps and rubella vaccine, live
they decrease the efficacy of live vaccines
Pharmacodynamic synergism between abciximab and ginger may extend the bleeding period.
>10%:Â
Bleeding, minor Â
Bleeding, major Â
Hypotension Â
Back pain Â
Nausea Â
Chest pain Â
Vomiting Â
1-10%:Â
Headache Â
Thrombocytopenia Â
Bradycardia Â
Injection site pain Â
Extremity pain Â
UTIÂ
Abdominal pain Â
Dizziness Â
Peripheral edema Â
Anemia Â
Diarrhea Â
Hypoesthesia Â
Â
Abciximab is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.Â
Pregnancy consideration:Â Â
Category C.Â
Breastfeeding warnings:Â Â
No data is available regarding the excretion of the drug in breast milk.Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: abciximabÂ
Pronounced: ab-cix-imabÂ
Why do we use abciximab?Â
Abciximab belongs to the category of antiplatelet agents. It is used to treat unstable angina and helps prevent cardiac ischemia.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
